Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?
Authors:
- 1 January 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 199 (1) , 123-126
Abstract
No abstract availableKeywords
Funding Information
- Vaincre la mucoviscidose (RC20160501612/1/3/8)
- ABCF Protein Association
This publication has 5 references indexed in Scilit:
- Effects of Lumacaftor–Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulatorsScientific Reports, 2017
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTRNew England Journal of Medicine, 2015
- Sweat chloride as a biomarker of CFTR activity: Proof of concept and ivacaftor clinical trial dataJournal of Cystic Fibrosis, 2014
- Cystic fibrosisThe Lancet, 2009